Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Diaceutics ( (GB:DXRX) ) has issued an announcement.
Diaceutics PLC, a company operating in the diagnostics sector, has announced a notification of major holdings involving an acquisition of voting rights by West Elk Capital, LLC, based in Atlanta, USA. West Elk Partners, LP, from Delaware, USA, has crossed a threshold, now holding 3.12% of the voting rights in Diaceutics as of March 6, 2024, as part of an acquisition. This event signals a potential shift in shareholder composition and may influence company governance, impacting stakeholders and the market perception of Diaceutics.
More about Diaceutics
YTD Price Performance: -0.22%
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $131.9M
See more data about DXRX stock on TipRanks’ Stock Analysis page.
